Evidence map›Paper›PMID 33403828›Full record

ArticleBrain and behavior2021

How well do clinical and demographic characteristics predict Patient Health Questionnaire-9 scores among patients with treatment-resistant major depressive disorder in a real-world setting?

Jennifer Voelker, Kruti Joshi, Ella Daly, Eros Papademetriou, David Rotter, John J Sheehan, Harsh Kuvadia, Xing Liu, Anandaroop Dasgupta, Ravi Potluri

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jennifer VoelkerJanssen Scientific Affairs, LLC, Titusville, NJ, USA.ORCID 0000-0003-2356-0855
Kruti JoshiJanssen Scientific Affairs, LLC, Titusville, NJ, USA.
Ella DalyJanssen Research & Development, LLC, Titusville, NJ, USA.
Eros PapademetriouSmartAnalyst, Inc, New York, NY, USA.
David RotterSmartAnalyst, Inc, New York, NY, USA.
John J SheehanJanssen Scientific Affairs, LLC, Titusville, NJ, USA.
Harsh KuvadiaIntegrated Resources, Inc., Edison, NJ, USA.
Xing LiuSmartAnalyst, Inc, New York, NY, USA.
Anandaroop DasguptaSmartAnalyst, Inc, New York, NY, USA.
Ravi PotluriSmartAnalyst, Inc, New York, NY, USA.
Sonalysts (United States) · USJanssen (United States) · USEdison Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo create and validate a model to predict depression symptom severity among patients with treatment-resistant depression (TRD) using commonly recorded variables within medical claims databases.

methodsAdults with TRD (here defined as > 2 antidepressant treatments in an episode, suggestive of nonresponse) and ≥ 1 Patient Health Questionnaire (PHQ)-9 record on or after the index TRD date were identified (2013-2018) in Decision Resource Group's Real World Data Repository, which links an electronic health record database to a medical claims database. A total of 116 clinical/demographic variables were utilized as predictors of the study outcome of depression symptom severity, which was measured by PHQ-9 total score category (score: 0-9 = none to mild, 10-14 = moderate, 15-27 = moderately severe to severe). A random forest approach was applied to develop and validate the predictive model.

resultsAmong 5,356 PHQ-9 scores in the study population, the mean (standard deviation) PHQ-9 score was 10.1 (7.2). The model yielded an accuracy of 62.7%. For each predicted depression symptom severity category, the mean observed scores (8.0, 12.2, and 16.2) fell within the appropriate range.

conclusionsWhile there is room for improvement in its accuracy, the use of a machine learning tool that predicts depression symptom severity of patients with TRD can potentially have wide population-level applications. Healthcare systems and payers can build upon this groundwork and use the variables identified and the predictive modeling approach to create an algorithm specific to their population.

Indexed as

Depressive Disorder, Treatment-ResistantMajor Depressive DisorderAdultAntidepressive AgentsDemographyHumansPatient Health QuestionnaireAntidepressive Agentsdepressiondepression severityPatient Health Questionnaire-9treatment-resistant major depressive disorder

Identifiers

PMID33403828
PMCPMC7882175
OpenAlexW3119928076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.